FDA drug-review, surveillance processes under scrutiny.
Miller
J L
JL
D002839:Chromans / Q000009:adverse effects; D017277:Drug Approval / Q000379:methods; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D017093:Liver Failure / Q000139:chemically induced; D011358:Product Surveillance, Postmarketing; D013844:Thiazoles / Q000009:adverse effects; D045162:Thiazolidinediones; D000077288:Troglitazone; D014481:United States; D014486:United States Food and Drug Administration / Q000592:standards*
D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone